Related Experiment Video
Updated: Jun 22, 2025

09:22
Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles
Published on: October 13, 2017
11.9K
Lysozyme-sensitive plasmonic hydrogel nanocomposite for colorimetric dry-eye inflammation biosensing
Yasamin Ziai1, Chiara Rinoldi1, Francesca Petronella2
1Department of Biosystems and Soft Matter, Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw 02-106, Poland.
Nanoscale
|June 28, 2024
Summary
This study presents a novel hydrogel-based biosensor for detecting lysozyme in eye fluids. The sensitive and rapid colorimetric sensor offers a promising tool for early diagnosis of eye conditions like dry-eye syndrome.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Ophthalmology
Background:
- Lysozyme detection in ocular fluids is vital for diagnosing eye conditions such as dry-eye syndrome.
- Hydrogel nanocomposites offer a promising platform for rapid and accurate biomolecule sensing.
Purpose of the Study:
- To develop a sensitive, easy-to-use biosensor for lysozyme detection in ocular fluids.
- To create a colorimetric platform for non-invasive monitoring of eye health.
Main Methods:
- Fabrication of a biosensor combining hydrogel, electrospun nanofibers (PLCL), and plasmonic nanoparticles (AgNPls).
- Utilizing localized surface plasmon resonance (LSPR) for quantitative detection.
- Characterization of platform layers and investigation of lysozyme detection using colorimetry and UV-Vis spectroscopy.
Main Results:
- The developed biosensor demonstrated high sensitivity and rapid response time for lysozyme detection.
- The platform exhibited a colorimetric response, enabling naked-eye detection.
- Lysozyme detection was validated at concentrations relevant to dry-eye syndrome and other ocular diseases.
Conclusions:
- The novel hydrogel-based biosensor is a promising tool for early diagnosis and monitoring of eye diseases.
- The sensor's sensitivity, rapid response, and ease of use facilitate non-invasive ocular diagnostics.
- This technology holds potential for improved patient outcomes in ophthalmology.

